![]() |
Volumn 365, Issue 9463, 2005, Pages 936-937
|
Evidenced-based decision making about Hib vaccination [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
BACTERIAL POLYSACCHARIDE;
HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE;
HAEMOPHILUS VACCINE;
ASIAN;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
HAEMOPHILUS INFLUENZAE TYPE B;
HUMAN;
INCIDENCE;
INFLUENZA;
LETTER;
MEDICAL DECISION MAKING;
MEDICAL DOCUMENTATION;
PREVENTIVE HEALTH SERVICE;
PRIORITY JOURNAL;
VACCINATION;
BACTERIAL INFECTION;
DEVELOPING COUNTRY;
HEALTH CARE POLICY;
INTERNATIONAL COOPERATION;
NOTE;
DEVELOPING COUNTRIES;
EVIDENCE-BASED MEDICINE;
HAEMOPHILUS INFECTIONS;
HAEMOPHILUS VACCINES;
HEALTH POLICY;
HUMANS;
INTERNATIONAL AGENCIES;
POLYSACCHARIDES, BACTERIAL;
VACCINATION;
|
EID: 15844415300
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)71076-X Document Type: Letter |
Times cited : (12)
|
References (4)
|